Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)

The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS. * The opportunity is focused on novel mechanism research on NPS in Alzheimer's dementia. * The funding instrument for this opportunity is a grant. * Eligible applicants include various organizations such as state governments, public and state-controlled institutions of higher education, non-profits, and small businesses. * The expected application count is 100, and the application size is not specified.